IC
ALXN

IKOS CIF’s Alexion Pharmaceuticals ALXN Stock Holding History

IKOS CIF’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$105K Buy
+839
New +$108K 0.63% 45
2015
Q2 		– Sell
-2,008
Closed -$361K – 308
2015
Q1 		$361K Sell
2,008
-224
-10% -$40.5K 0.83% 30
2014
Q4 		$414K Buy
+2,232
New +$414K 0.7% 43

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

IKOS CIF's ALXN Position: Q3 2016 in Review

IKOS CIF opened a new position in Alexion Pharmaceuticals (ALXN) in Q3 2016: 839 shares worth $105K. The stake represents 0.63% of the portfolio and ranks #45 among its holdings. This is a return to the name: IKOS CIF previously reported a position in ALXN as recently as Q1 2015.

IKOS CIF first reported a position in ALXN in Q4 2014 and has held it in 3 quarters since. The position peaked at $414K in Q4 2014. 517 funds tracked by Wall St. Rank hold ALXN as of Q3 2016.

  • IKOS CIF held 839 shares of Alexion Pharmaceuticals worth $105K as of Q3 2016.
  • Alexion Pharmaceuticals was a new IKOS CIF position in Q3 2016.
  • Alexion Pharmaceuticals made up 0.63% of IKOS CIF's portfolio in Q3 2016, its #45 holding.
  • IKOS CIF first reported a position in Alexion Pharmaceuticals in Q4 2014 and has held it in 3 quarters since.
  • IKOS CIF's Alexion Pharmaceuticals position peaked at $414K in Q4 2014.
  • 517 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2016.

Based on IKOS CIF's 13F filing for Q3 2016, filed 10 Nov 2016.